Pharmacological studies of 3-(3,3-diphenylpropylamino)-propyl-3',4',5'-trimethoxybenzoate (PF-26), a new coronary vasodilator.
D000588:Amines / Q000633:toxicity; D000818:Animals; D001565:Benzoates / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D005260:Female; D005707:Gallic Acid / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007545:Isoproterenol; D008297:Male; D051379:Mice; D010101:Oxygen Consumption / Q000187:drug effects; D011437:Propylamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow; D013610:Tachycardia; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000633:toxicity
D000588:Amines; D001565:Benzoates; D011437:Propylamines; D014665:Vasodilator Agents; D005707:Gallic Acid; D007545:Isoproterenol